EURORDIS Position on Rare Disease Research

EURORDIS has produced two Position Papers that delineate the ethical, social, economic and scientific grounds that research on rare diseases rests upon.
The EURORDIS position calls for public policy intervention to address the shortcomings still to be overcome in this field: short-term investments, the large majority of RDs lacking a research project or a research ‘community’, scattered resources and expertise, scarce research on health economics and in socio-psychological areas.

RD research should not happen in isolation from health research in general. By feeding innovation, rare disease research contributes to EU competitiveness in a knowledge-based society. Nonetheless, the EURORDIS Position Papers argue that rare diseases should be a health research priority. Consequently, more substantial budgetary support for RD research should be provided in response to three main imperatives...

 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases